Latest intangible assets for RADLY: $980M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Raia Drogasil S.A. posts a intangible assets of $980M as of March 2026. That compares with $960M in the prior-year period — up 2.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Raia Drogasil S.A.'s intangible assets was $960M. The latest reading is $980M — a 2.1% year-over-year increase (period ending March 2026). Use the history and growth charts on this page for a longer lookback.
Intangible Assets is one piece of Raia Drogasil S.A.'s financial statement story. At $980M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for RADLY's intangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Raia Drogasil S.A.'s other metric pages and overview cover the third.
Judging Raia Drogasil S.A. against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in intangible assets easier to interpret. Start with $980M here, then scan peer and history charts to see if the gap is persistent.